Leading Innovation and Discovery and Delivering Life Saving Therapies
Healthy Ageing and Growing-up Healthy
SMDG is developing safe, innovative and disease-modifying therapies for some of the most debilitating diseases our societies face today. SMDG's team has focused on neurodegenerative diseases and paediatric neurological disorders as the first diseases to tackle. We do this by utilising our ground breaking and transformative platforms for targeted and safe delivery of therapies and genetic medicines and broad understanding of these diseases for designing first in-class therapeutics.
Get to Know Us
SMDG is a biotechnology company focusing on developing novel, safe and effective therapies for most debilitating diseases. We are a team of scientists, innovators and entrepreneurs with extensive experience in studying nature of different diseases and designing most innovative therapeutics. We have embarked on an ambitious path of designing better disease modifying and first in-class therapies that are safe for patients and are good for the environment. The science of nanotherapeutics is at the beginning stages of creating realistic, effective and safe therapies and we are at the forefront of this field.
News
SMDG Announces Appointment of Industry Leader Dr Zsuzsanna Devecseri to the Board of Directors
Dr Shadi Farhangrazi has been recognised for the CEO of the Year Award by the SME News
Dr Shadi Farhangrazi invited to a Fireside Chat for International Women's Day